Conduit Pharmaceuticals CDT 深 滬
已收盤 07-02 16:00:00 美东时间
0.4941
-0.030
-5.71%
華盛通- 最 高0.5255
- 今 開0.5151
- 成交量 64.83万股
- 最 低 0.4672
- 昨 收 0.524
- 總市值 240.05万
- 52周最高 492.00
- 市盈率 靜 --
- 換手率 13.34%
- 52周最低 0.4672
- 委 比 -93.20%
- 總股本 485.84万
- 歷史最高 7500000.00
- 量 比 0.58
- 振 幅 11.13%
- 歷史最低 0.4672
- 每 手 1
- 風險率 143.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
CDT Equity Inc. announced that Sarborg Limited has expanded its Signature Intelligence platform into quantum-assisted coformer selection through SarborgQ, the Company's quantum computing division. Sarborg is integrating its proprietary datasets, AI architecture, and quantum computing to accelerate solid-form development, improve decision-making, and identify new co-crystal, salt, and solid-form opportunities. The initiative aims to enhance Sarbor...
06-26 12:30
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers PRF Technologies (NASDAQ:PRFX) stock rose 231.0% to $4.54 during Frida...
05-30 01:06
CDT Equity Receives Nasdaq Noncompliance Letter
CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that the Company received a written notice ("Notice") from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on
05-29 04:24
CDT Equity Secures Canadian Patent Covering Use Of AZD5904 In Male Infertility
CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that the patent covering the use of AZD5904 in male infertility has now been granted in Canada, completing the approval of this patent in all key
05-27 20:03
CDT Announces Canadian Patent for AZD5904 in Male Infertility
CDT Equity Inc. announced the grant of a patent for AZD5904 in male infertility in Canada, completing approval in key markets. The extensive patent coverage and composition of matter application strengthen its IP position for development. AZD5904, originally licensed from AstraZeneca, addresses a significant unmet medical need in a $4.4 billion global market. The Canadian approval enhances global positioning as CDT advances partnering discussions...
05-27 12:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) stock increased by 12.5% to $3.11 during Mond...
05-19 05:05
CDT Equity Unit Sarborg Files Parent Covering Two Established Compounds Within The Cystic Fibrosis Market
Sarborg announced that the patent was developed using its proprietary Signature Agent and Multi-Agent platform, supported by its Sarborg 1,600 Disease Database and Sarborg 1,700 Rare Disease Database. According to
05-07 20:38
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 19.1% to $16.23 during ...
04-25 05:05
What's Going On With CDT Equity Shares On Monday?
CDT Equity moves higher ahead of earnings, recovering from last week's decline tied to delayed SEC filing and expectations of wider net losses.
04-14 00:38
